Purpose and Content of Use-Related Risk Analyses for Drugs, Biological Products, and Combination Products

Information

Type

Guidance

Regulated products

Biologics, Drugs, Medical Devices

Published

July 8, 2024

Last updated

July 9, 2024

Description

Guidance document outlining the purpose and content of use-related risk analyses for drugs, biological products, and combination products.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed